The coagglutination test, which uses staphylococcal protein A, for serotyping strains of Streptococcus pneumoniae, was extended to include serotyping within serogroups. Serotyping was performed with "factor sera" prepared in the laboratory. Fifty one strains of S pneumoniae, which belonged to one of the seven serogroups included in the 14 valent vaccine formulation, were tested, and no inconsistency was found when compared with the capsule swelling reaction. Smart 
Serotyping of Streptococcus pneumoniae is a valuable epidemiological tool and provides information about the potential of available pneumococcal vaccines (Pneumovax and for protecting subjects from specific pneumococcal infections. It is not known whether vaccination with a given serotype protects against infections by related types being contained within the same serogroup. The distribution of serotypes associated with infection varies geographically and according to the age of the patient,' and it is therefore important to have data on incidence of serotype and distribution.
Most isolates of S pneumoniae in man are capsulate. Differences in the composition and structure of the capsular material allow 83 serotypes to be distinguished. In the Danish nomenclature, now universally accepted, there are 27 monotypes and 19 serogroups. The serogroups consist of between two and four types that possess common antigenic determinants but which can be distinguished serologically. The 19 serogroups are thus divided into 56 serotypes using specially prepared "factor sera" that are rendered monospecific by absorption.2 Typing of pneumococci by means of the capsule swelling reaction,3 counterimmunoelectrophoresis,4 and coagglutination,' with commercially available pneumococcal antisera can identify strains belonging to one of the 27 monotypes or 19 serogroups. Serotyping within serogroups, however, requires specially prepared "factor sera," which are not commercially available. Henrichsen6 compared the capsule swelling reaction with counterimmunoelectrophoresis for serotyping pneumococci and for serotyping within serogroups. He found that the capsule swelling reac-Accepted for publication 2 December 1985 tion was preferable. Coagglutination, however, is an alternative technique to capsule swelling for serotyping and correlates well with that technique.5 Furthermore, coagglutination is rapid and economical.7 This paper describes the extension of the coagglutination test to serotyping within serogroups using specially prepared "factor sera."
Material and methods

Reference strains of S pneumoniae
Concentrated suspensions for the preparation of antisera and for absorption (see below) were prepared from clinical isolates that had been serotyped, or supplied as lyophilised cultures by Dr J Henrichsen, Streptococcus Department, Statens Seruminstitut, Copenhagen.
PREPARATION OF STOCK PNEUMOCOCCAL SUSPENSIONS
The growth from two blood agar plates (incubated anaerobically with 5-10% carbon dioxide for 18 hours) was used to inoculate 500 ml of Todd Hewitt broth (Difco 0492-01) containing 5% horse serum (Gibco Europe 034-6050). Cultures were incubated at 37°C for four to seven hours aerobically until growth was in the late log phase. Subculture was carried out to confirm purity, and 2% (vol/vol) formaldehyde was added. The suspensions were left overnight at room temperature. The bacterial cells were then harvested by centrifugation (3500 rpm for 30 minutes), and washed twice with phosphate buffered saline (PBS, pH 7 2) containing 0 5% formaldehyde. Concentrated suspension (10 pl) was resuspended to 1 ml in phosphate buffered saline and filmed to confirm that all the bacteria were Gram positive and possessed Serotyping of Streptococcus pneumoniae a well developed capsule. Stock suspensions were stored at 4°C. PNEUMOCOCCAL ANTISERA Diagnostic pneumococcal antisera were obtained from the Statens Seruminstitut, Copenhagen. Antisera to types 6A, 6B, 7F, 7A, 7B, 7C, 9N, 9A, 9V, 9L, 12F, 12A, 18F, 18A, 18B, 18C, l9F, 19A, 19C, 23F, 23A, and 28 were raised in rabbits using inocula prepared from stock pneumococcal suspensions diluted in phosphate buffered saline to give 1-2 x 109 diplococci/ml (Lund and Henrichsen.3)
PREPARATION OF STABILISED STAPHYLOCOCCI (PROTEIN A)
Staphylococcus aureus Cowan 1 (NCTC 8530) was grown on plates of CCY agar (Woodin modification), overlaid with dialysis membrane (Technicon part number 933-0225-01), and incubated at 37°C overnight. The bacteria were harvested from the membranes by agitation in phosphate buffered saline, the suspension washed twice in phosphate buffered saline, and suspended in 0 5% formaldehyde in phosphate buffered saline for two hours at room temperature. The formolinised suspension was washed twice in phosphate buffered saline, heated at 80°C for one hour,5 washed a further three times in phosphate buffered saline, and resuspended at a concentration of 10% (vol/vol) in phosphate buffered saline containing 0-1 % sodium azide.
PRODUCTION OF FACTOR SERA
Antisera to types 6A, 6B, 7F, 7A, 7B, 7C, 9N, 9A, 9V, 9L, 12F, 12A, 18F, 18A, 18B, 18C, 19A, 19F, 19C, 23A, and 23F were absorbed with formolinised suspensions of the appropriate heterologous strains to remove common serogroup antibodies and to produce factor sera2 as follows. Formolinised suspension (500 p1) was centrifuged at 3500 rpm for 30 minutes, and the supernatant fluid removed. Antiserum (250 p1) was absorbed by resuspending the bacterial deposit in the serum at room temperature for 15-30 minutes. A second absorption was carried out in the same way using 500 pl of the same suspension. Absorbed serum (50 p1) was mixed with 500 pl of protein A and tested against appropriate suspensions of serotypes to confirm complete removal of homologous antibody. Although two absorptions were generally sufficient to remove all homologous antibody, some high titre antisera required a further absorption. COAGGLUTINATION Fifty microlitres of each antiserum (Pools A-I) serogroup sera and monotypic sera (Statens Seruminstitut, Copenhagen) were added to 500 p1 of stabilised staphylococcal suspension. These reagents 329 were used for serotyping clinical isolates of S pneumoniae as follows. Ten to 20 colonies of Spneumoniae from an overnight anaerobic culture on blood agar were emulsified in 0 5 ml of phosphate buffered saline. Tests were performed on 3 by 1 inch glass slides by mixing 1 p1 of bacterial suspension with 1 u1 of each of nine coagglutination reagents (Pool A-I, Statens Seruminstitut). The individual monotype or serogroup was determined by testing with single monotype or serogroup reagents appropriate to the pool that gave the positive reaction. The reactions were read by detecting visible clumping after rocking the slide to and fro for two minutes. Only strong reactions appearing within the two minutes were considered to be specific for pneumococcal capsular polysaccharide. In most instances positive reactions were detected in a few seconds.
Serotyping within the seven serogroups (6, 7, 9, 12, 18, 19, and 23) represented in the 14 valent vaccine was performed using coagglutination reagents prepared from factor sera. The serotype was determined from the results of the coagglutination test when each strain was tested with each factor serum for the serogroup, according to the typing scheme set out by Lund and Henrichsen.3 Results Table 1 shows the results of the coagglutination test with factor sera performed on stock reference strains of S pneumoniae. The reactions observed with factor sera adsorbed to protein A agreed with the reactions given by capsule swelling (Lund and Henrichsen3). Table 2 details the results of the coagglutination test and the capsule swelling reaction performed on 51 clinical isolates of S pneumoniae, which belonged to one of the seven serogroups in the 14 valent vaccine.
For clinical isolates the results of serotyping within serogroups using appropriate factor sera adsorbed to staphylococcal protein A agreed with the results obtained by capsule swelling.
Discussion
The results show that factor sera adsorbed to staphylococcal protein A can accurately serotype strains of S pneumoniae by coagglutination. Although only a limited number of serotypes within serogroups are reported here, the results of the coagglutination test and capsule swelling were in complete agreement, and there is no reason to suspect that the results obtained were atypical.
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